Case number 1:22-cv-00042
Eagle Pharmaceuticals, Inc. v. Celerity Pharmaceuticals, LLC, et al., > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Nov 16, 2022 | 109 | Official Transcript of Markman Hearing held on September 15, 2022 before Chief Judge Connolly. Court Reporter/Transcriber Bonnie Archer, Email: bonnie_archer@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 12/7/2022. Redacted Transcript Deadline set for 12/19/2022. Release of Transcript Restriction set for 2/14/2023. (nmf) (Entered: 11/16/2022) (0) |
| Oct 28, 2022 | 106 | STIPULATION [Proposed] Stipulated Final Judgment of Non-Infringement and Order of Dismissal by Baxter Healthcare Corporation, Celerity Pharmaceuticals, LLC. (Rovner, Philip) (Entered: 10/28/2022) (5) |
| Oct 28, 2022 | 107 | SO ORDERED, re 106 Stipulated Final Judgment of Non-Infringement and Order of Dismissal, filed by Baxter Healthcare Corporation, Celerity Pharmaceuticals, LLC. CASE CLOSED. Signed by Judge Colm F. Connolly on 10/28/2022. (kmd) (Entered: 10/28/2022) (5) |
| Oct 28, 2022 | 108 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 11,103,483. (Attachments: # 1 Stipulated Final Judgment of Non-Infringement and Order of Dismissal)(kmd) (Entered: 10/28/2022) (Main Document) (1) |
| Oct 28, 2022 | 108 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 11,103,483. (Attachments: # 1 Stipulated Final Judgment of Non-Infringement and Order of Dismissal)(kmd) (Entered: 10/28/2022) (Stipulated Final Judgment of Non-Infringement and Order of Dismissal) (5) |
| Oct 21, 2022 | 105 | Letter to The Honorable Colm F. Connolly from Philip A. Rovner regarding joint status report - re 103 SO ORDERED,, Case Stayed,, Set Scheduling Order Deadlines,. (Attachments: # 1 Exhibit A)(Rovner, Philip) (Entered: 10/21/2022) (Main Document) (2) |
| Oct 21, 2022 | 105 | Letter to The Honorable Colm F. Connolly from Philip A. Rovner regarding joint status report - re 103 SO ORDERED,, Case Stayed,, Set Scheduling Order Deadlines,. (Attachments: # 1 Exhibit A)(Rovner, Philip) (Entered: 10/21/2022) (Exhibit A) (6) |
| Oct 20, 2022 | 104 | Letter to The Honorable Colm F. Connolly from Philip A. Rovner regarding discovery conference. (Attachments: # 1 Exhibit A)(Rovner, Philip) (Entered: 10/20/2022) (Main Document) (3) |
| Oct 20, 2022 | 104 | Letter to The Honorable Colm F. Connolly from Philip A. Rovner regarding discovery conference. (Attachments: # 1 Exhibit A)(Rovner, Philip) (Entered: 10/20/2022) (Exhibit A) (6) |
| Oct 12, 2022 | 102 | Joint STIPULATION and [Proposed] Order Staying Case by Celerity Pharmaceuticals, LLC. (Rovner, Philip) (Entered: 10/12/2022) (5) |
| Oct 12, 2022 | 103 | SO ORDERED, re 102 Stipulation Staying Case, filed by Celerity Pharmaceuticals, LLC. Case stayed. Resetting Scheduling Order Deadlines: Fact Discovery completed by 12/2/2022. Expert Discovery due by 4/3/2023. Signed by Judge Colm F. Connolly on 10/12/2022. (kmd) (Entered: 10/12/2022) (5) |
| Oct 11, 2022 | 101 | NOTICE requesting Clerk to remove Jennifer Koh as co-counsel.. (Joyce, Alexandra) (Entered: 10/11/2022) (3) |
| Sep 30, 2022 | 99 | NOTICE OF SERVICE of Celerity's Objections and Supplemental Responses to Plaintiff's Interrogatory Nos. 1, 3, and 9 [Confidential - Subject to Protective Order - Counsels' Eyes Only] filed by Celerity Pharmaceuticals, LLC.(Rovner, Philip) (Entered: 09/30/2022) (3) |
| Sep 30, 2022 | 100 | NOTICE OF SERVICE of Notice of Amended Subpoenas to Baker & Hostetler, Lucas & Mercanti, Stephanie Lodise, Michael N. Mercanti, Nagesh Palepu and SciDose LLC filed by Celerity Pharmaceuticals, LLC.(Rovner, Philip) (Entered: 09/30/2022) (3) |
| Sep 26, 2022 | 98 | NOTICE OF SERVICE of Plaintiff's Objections and Responses to Defendant's Second 30(B)(6) Notice filed by Eagle Pharmaceuticals, Inc..(Silver, Daniel) (Entered: 09/26/2022) (3) |
| Sep 23, 2022 | 97 | Letter to The Honorable Colm F. Connolly from Daniel M. Silver regarding response to request for a status conference - re 94 Letter. (Silver, Daniel) (Entered: 09/23/2022) (1) |
| Sep 22, 2022 | 96 | CLAIM CONSTRUCTION ORDER re (95 in 1:22-cv-00042-CFC, 73 in 1:21-cv-00952-CFC, 97 in 1:21-cv-00695-CFC) Proposed Order filed by Eagle Pharmaceuticals, Inc. Signed by Judge Colm F. Connolly on 9/22/2022. Associated Cases: 1:21-cv-00695-CFC, 1:21-cv-00952-CFC, 1:22-cv-00042-CFC(nmf) (Entered: 09/22/2022) (4) |
| Sep 21, 2022 | 94 | Letter to The Honorable Colm F. Connolly from Philip A. Rovner regarding request for conference. (Rovner, Philip) (Entered: 09/21/2022) (2) |
| Sep 21, 2022 | 95 | PROPOSED ORDER Claim Construction by Eagle Pharmaceuticals, Inc.. (Joyce, Alexandra) (Entered: 09/21/2022) (4) |
| Sep 19, 2022 | 93 | NOTICE OF SERVICE of Plaintiff's Responses to Defendant Celerity Pharmaceuticals, LLC's Second Set of Interrogatories filed by Eagle Pharmaceuticals, Inc..(Silver, Daniel) (Entered: 09/19/2022) (3) |
| Sep 15, 2022 | 92 | REDACTED VERSION of 82 Response to Motion for Leave to File Sur-Surreply Brief by Celerity Pharmaceuticals, LLC. (Attachments: # 1 Exhibit 1-2)(Rovner, Philip) (Entered: 09/15/2022) (Main Document) (8) |
| Sep 15, 2022 | 92 | REDACTED VERSION of 82 Response to Motion for Leave to File Sur-Surreply Brief by Celerity Pharmaceuticals, LLC. (Attachments: # 1 Exhibit 1-2)(Rovner, Philip) (Entered: 09/15/2022) (Exhibit 1-2) (14) |
| Sep 14, 2022 | 91 | NOTICE OF SERVICE of Celerity Pharmaceuticals, LLC's Second Notice of Rule 30(b)(6) Deposition of Eagle Pharmaceuticals Inc. filed by Celerity Pharmaceuticals, LLC.(Rovner, Philip) (Entered: 09/14/2022) (3) |
| Sep 13, 2022 | 86 | SO ORDERED, re (66 in 1:21-cv-00952-CFC) (85 in 1:22-cv-00042-CFC) (90 in 1:21-cv-00695-CFC) STIPULATION TO EXTEND TIME to File Public Versions of the Joint Claim Construction Brief, Appendix to the Joint Claim Construction Brief, and Motion for Leave to File Sur-Reply to September 13, 2022, filed by Cephalon, LLC, Teva Pharmaceuticals International GmbH, Eagle Pharmaceuticals, Inc. Signed by Judge Colm F. Connolly on 9/13/2022. Associated Cases: 1:21-cv-00695-CFC, 1:21-cv-00952-CFC, 1:22-cv-00042-CFC(kmd) (Entered: 09/13/2022) (4) |
| Sep 13, 2022 | 87 | MOTION for Pro Hac Vice Appearance of Attorney David Kowalski - filed by Eagle Pharmaceuticals, Inc.. (Joyce, Alexandra) (Entered: 09/13/2022) (5) |
| Sep 13, 2022 | 88 | REDACTED VERSION of 77 Joint Claim Construction Brief by Eagle Pharmaceuticals, Inc.. (Joyce, Alexandra) (Entered: 09/13/2022) (30) |
| Sep 13, 2022 | 89 | REDACTED VERSION of 78 Appendix, by Eagle Pharmaceuticals, Inc.. (Attachments: # 1 Exhibits 1-4, # 2 Exhibits 5-10, # 3 Exhibits 11-20, # 4 Exhibits 21-30, # 5 Exhibits 31-40, # 6 Exhibits 41-48, # 7 Exhibits 49-52, # 8 Exhibits 53-60, # 9 Exhibits 61-73)(Joyce, Alexandra) (Entered: 09/13/2022) (Main Document) (12) |
| Sep 13, 2022 | 90 | REDACTED VERSION of 79 MOTION for Leave to File Surreply Claim Construction Brief by Eagle Pharmaceuticals, Inc.. (Joyce, Alexandra) (Entered: 09/13/2022) (22) |
| Sep 13, 2022 | 89 | REDACTED VERSION of 78 Appendix, by Eagle Pharmaceuticals, Inc.. (Attachments: # 1 Exhibits 1-4, # 2 Exhibits 5-10, # 3 Exhibits 11-20, # 4 Exhibits 21-30, # 5 Exhibits 31-40, # 6 Exhibits 41-48, # 7 Exhibits 49-52, # 8 Exhibits 53-60, # 9 Exhibits 61-73)(Joyce, Alexandra) (Entered: 09/13/2022) (Exhibits 1-4) (30) |
| Sep 13, 2022 | 89 | REDACTED VERSION of 78 Appendix, by Eagle Pharmaceuticals, Inc.. (Attachments: # 1 Exhibits 1-4, # 2 Exhibits 5-10, # 3 Exhibits 11-20, # 4 Exhibits 21-30, # 5 Exhibits 31-40, # 6 Exhibits 41-48, # 7 Exhibits 49-52, # 8 Exhibits 53-60, # 9 Exhibits 61-73)(Joyce, Alexandra) (Entered: 09/13/2022) (Exhibits 5-10) (30) |
| Sep 13, 2022 | 89 | REDACTED VERSION of 78 Appendix, by Eagle Pharmaceuticals, Inc.. (Attachments: # 1 Exhibits 1-4, # 2 Exhibits 5-10, # 3 Exhibits 11-20, # 4 Exhibits 21-30, # 5 Exhibits 31-40, # 6 Exhibits 41-48, # 7 Exhibits 49-52, # 8 Exhibits 53-60, # 9 Exhibits 61-73)(Joyce, Alexandra) (Entered: 09/13/2022) (Exhibits 11-20) (30) |
| Sep 13, 2022 | 89 | REDACTED VERSION of 78 Appendix, by Eagle Pharmaceuticals, Inc.. (Attachments: # 1 Exhibits 1-4, # 2 Exhibits 5-10, # 3 Exhibits 11-20, # 4 Exhibits 21-30, # 5 Exhibits 31-40, # 6 Exhibits 41-48, # 7 Exhibits 49-52, # 8 Exhibits 53-60, # 9 Exhibits 61-73)(Joyce, Alexandra) (Entered: 09/13/2022) (Exhibits 21-30) (30) |
| Sep 13, 2022 | 89 | REDACTED VERSION of 78 Appendix, by Eagle Pharmaceuticals, Inc.. (Attachments: # 1 Exhibits 1-4, # 2 Exhibits 5-10, # 3 Exhibits 11-20, # 4 Exhibits 21-30, # 5 Exhibits 31-40, # 6 Exhibits 41-48, # 7 Exhibits 49-52, # 8 Exhibits 53-60, # 9 Exhibits 61-73)(Joyce, Alexandra) (Entered: 09/13/2022) (Exhibits 31-40) (30) |
| Sep 13, 2022 | 89 | REDACTED VERSION of 78 Appendix, by Eagle Pharmaceuticals, Inc.. (Attachments: # 1 Exhibits 1-4, # 2 Exhibits 5-10, # 3 Exhibits 11-20, # 4 Exhibits 21-30, # 5 Exhibits 31-40, # 6 Exhibits 41-48, # 7 Exhibits 49-52, # 8 Exhibits 53-60, # 9 Exhibits 61-73)(Joyce, Alexandra) (Entered: 09/13/2022) (Exhibits 41-48) (30) |
| Sep 13, 2022 | 89 | REDACTED VERSION of 78 Appendix, by Eagle Pharmaceuticals, Inc.. (Attachments: # 1 Exhibits 1-4, # 2 Exhibits 5-10, # 3 Exhibits 11-20, # 4 Exhibits 21-30, # 5 Exhibits 31-40, # 6 Exhibits 41-48, # 7 Exhibits 49-52, # 8 Exhibits 53-60, # 9 Exhibits 61-73)(Joyce, Alexandra) (Entered: 09/13/2022) (Exhibits 49-52) (15) |
| Sep 13, 2022 | 89 | REDACTED VERSION of 78 Appendix, by Eagle Pharmaceuticals, Inc.. (Attachments: # 1 Exhibits 1-4, # 2 Exhibits 5-10, # 3 Exhibits 11-20, # 4 Exhibits 21-30, # 5 Exhibits 31-40, # 6 Exhibits 41-48, # 7 Exhibits 49-52, # 8 Exhibits 53-60, # 9 Exhibits 61-73)(Joyce, Alexandra) (Entered: 09/13/2022) (Exhibits 53-60) (30) |
| Sep 13, 2022 | 89 | REDACTED VERSION of 78 Appendix, by Eagle Pharmaceuticals, Inc.. (Attachments: # 1 Exhibits 1-4, # 2 Exhibits 5-10, # 3 Exhibits 11-20, # 4 Exhibits 21-30, # 5 Exhibits 31-40, # 6 Exhibits 41-48, # 7 Exhibits 49-52, # 8 Exhibits 53-60, # 9 Exhibits 61-73)(Joyce, Alexandra) (Entered: 09/13/2022) (Exhibits 61-73) (30) |
| Sep 9, 2022 | 83 | CLAIM Construction Chart by Eagle Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A - 483 Patent, # 2 Exhibit B - 887 Patent)(Joyce, Alexandra) (Entered: 09/09/2022) (Main Document) (19) |
| Sep 9, 2022 | 84 | Letter to Chief Judge Colm F. Connolly from Alexandra M. Joyce regarding Claims Construction Chart - re 83 Claim Construction Chart. (Joyce, Alexandra) (Entered: 09/09/2022) (2) |
| Sep 9, 2022 | 85 | STIPULATION TO EXTEND TIME to file public versions of (1) Joint Claim Construction Brief, (2) Appendix, and (3) Motion for Leave to File Sur-Reply to September 13, 2022 - filed by Eagle Pharmaceuticals, Inc.. (Joyce, Alexandra) (Entered: 09/09/2022) (4) |
| Sep 9, 2022 | 83 | CLAIM Construction Chart by Eagle Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A - 483 Patent, # 2 Exhibit B - 887 Patent)(Joyce, Alexandra) (Entered: 09/09/2022) (Exhibit A - 483 Patent) (13) |
| Sep 9, 2022 | 83 | CLAIM Construction Chart by Eagle Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A - 483 Patent, # 2 Exhibit B - 887 Patent)(Joyce, Alexandra) (Entered: 09/09/2022) (Exhibit B - 887 Patent) (18) |
| Sep 8, 2022 | 82 | [SEALED] RESPONSE to Motion re 79 MOTION for Leave to File Surreply Claim Construction Brief filed by Celerity Pharmaceuticals, LLC. (Attachments: # 1 Exhibit 1-2)(Rovner, Philip) (Entered: 09/08/2022) (0) |
| Sep 7, 2022 | 80 | ORDER: Having read the parties' claim construction briefing (D.1. 84) and having reviewed the December 15, 2020 hearing transcript and related briefing in Eagle Pharms. Inc. v. Hospira, Inc., C.A. No. 18-1074-CFC-CJB, I will construe the claim term "a non-aqueous liquid composition" to mean "a solution in which water does not make up a substantial portion and is not a significant solvent." Oral argument for the upcoming Markman Hearing will focus solely on the disputed term "ready to use" and will be limited to one hour. Signed by Judge Colm F. Connolly on 9/7/2022. Associated Cases: 1:21-cv-00695-CFC, 1:21-cv-00952-CFC, 1:22-cv-00042-CFC(nmf) (Entered: 09/07/2022) (2) |
| Sep 7, 2022 | 81 | NOTICE OF SERVICE of Celerity Pharmaceuticals, LLC's Notice of Rule 30(b)(6) Deposition of Eagle Pharmaceuticals Inc. filed by Celerity Pharmaceuticals, LLC.(Rovner, Philip) (Entered: 09/07/2022) (3) |
| Sep 2, 2022 | 76 | NOTICE OF SERVICE of Subpoena upon Stephanie A. Lodise filed by Celerity Pharmaceuticals, LLC.(Choa, Jonathan) (Entered: 09/02/2022) (2) |
| Sep 2, 2022 | 77 | [SEALED] JOINT CLAIM CONSTRUCTION BRIEF filed by Eagle Pharmaceuticals, Inc.. (Attachments: # 1 Certificate of Service)(Joyce, Alexandra) (Entered: 09/02/2022) (0) |
| Sep 2, 2022 | 78 | [SEALED] Joint APPENDIX re 77 Joint Claim Construction Brief by Eagle Pharmaceuticals, Inc.. (Attachments: # 1 Exs. 1-4, # 2 Exs. 5-10, # 3 Exs. 11-20, # 4 Exs. 21-30, # 5 Exs. 31-40, # 6 Exs. 41-48, # 7 Exs. 49-52, # 8 Exs. 53-60, # 9 Exs. 61-73, # 10 Certificate of Service)(Joyce, Alexandra) (Entered: 09/02/2022) (0) |
| Sep 2, 2022 | 79 | [SEALED] MOTION for Leave to File Surreply Claim Construction Brief - filed by Eagle Pharmaceuticals, Inc.. (Attachments: # 1 Ex. A, # 2 Ex. B, # 3 Ex. C, # 4 Certificate of Service)(Joyce, Alexandra) (Entered: 09/02/2022) (0) |
| Sep 1, 2022 | 75 | STIPULATION and [Proposed] Order regarding Joint Claim Construction Brief by Eagle Pharmaceuticals, Inc.. (Joyce, Alexandra) (Entered: 09/01/2022) (4) |
| Aug 31, 2022 | 74 | NOTICE OF SERVICE of subpoenas upon Lucas & Mercanti, LLP, Christina Jordan and Michael N. Mercanti filed by Celerity Pharmaceuticals, LLC.(Rovner, Philip) (Entered: 08/31/2022) (2) |
| Aug 29, 2022 | 73 | NOTICE OF SERVICE of Defendants' Sur-Reply Claim Construction Brief filed by Celerity Pharmaceuticals, LLC.(Rovner, Philip) (Entered: 08/29/2022) (3) |
| Aug 22, 2022 | 72 | NOTICE requesting Clerk to remove Kamilah Alexander as co-counsel.. (Silver, Daniel) (Entered: 08/22/2022) (2) |
| Aug 19, 2022 | 71 | NOTICE OF SERVICE of Celerity Pharmaceuticals, LLC's Second Set of Interrogatories to Eagle Pharmaceuticals, Inc. filed by Celerity Pharmaceuticals, LLC.(Rovner, Philip) (Entered: 08/19/2022) (3) |
| Aug 17, 2022 | 70 | NOTICE OF SERVICE of subpoena upon TherDose Pharma Pvt. Ltd., Nagesh R. Palepu, Baker & Hostetler LLP, Philip Christopher Buxton, and SciDose LLC filed by Celerity Pharmaceuticals, LLC.(Rovner, Philip) (Entered: 08/17/2022) (2) |
| Aug 15, 2022 | 69 | NOTICE OF SERVICE of Plaintiff's Reply Claim Construction Brief and Supporting Exhibits re 64 Claim Construction Chart, 67 Notice of Service, 68 Notice of Service, 63 Scheduling Order,, filed by Eagle Pharmaceuticals, Inc..(Silver, Daniel) (Entered: 08/15/2022) (2) |
| Aug 1, 2022 | 68 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Defendants' Responsive Claim Construction Brief filed by Celerity Pharmaceuticals, LLC.(Rovner, Philip) |
| Jul 12, 2022 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Martin J. Black for Celerity Pharmaceuticals, LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) |
| Jul 11, 2022 | 67 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiff's Opening Claim Construction Brief filed by Eagle Pharmaceuticals, Inc..(Joyce, Alexandra) |
| Jul 1, 2022 | 65 | Main Document (2) Docket Text: MOTION for Claim Construction re [64] Claim Construction Chart - filed by Eagle Pharmaceuticals, Inc.. (Attachments: # (1) Word Count Certification, # (2) Proposed Order)(Silver, Daniel) |
| Jul 1, 2022 | 65 | Word Count Certification (1) |
| Jul 1, 2022 | 65 | Proposed Order (1) |
| Jul 1, 2022 | 66 | Main Document (3) Docket Text: MOTION for Claim Construction - filed by Celerity Pharmaceuticals, LLC. (Attachments: # (1) Text of Proposed Order)(Rovner, Philip) |
| Jul 1, 2022 | 66 | Text of Proposed Order (1) |
| Jun 30, 2022 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Kamilah Alexander for Eagle Pharmaceuticals, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) |
| Jun 28, 2022 | 64 | Main Document (8) Docket Text: CLAIM Construction Chart by Eagle Pharmaceuticals, Inc.. (Attachments: # (1) Exhibit A - '483)(Silver, Daniel) |
| Jun 28, 2022 | 64 | Exhibit A - '483 (13) |
| Jun 24, 2022 | 62 | Letter (1) Docket Text: Email to Chief Judge Connolly from Philip A. Rovner, Esq. regarding joint request by the parties to enter the proposed scheduling order. (nmf) |
| Jun 24, 2022 | 63 | Scheduling Order (24) Docket Text: SCHEDULING ORDER: Fact Discovery completed by 11/18/2022. Expert Discovery due by 3/31/2023. Joint Claim Construction Brief due by 9/2/2022. A Markman Hearing is set for 9/15/2022 at 09:00 AM in Courtroom 4B before Judge Colm F. Connolly. Proposed Pretrial Order due by 4/7/2023. A Final Pretrial Conference is set for 4/25/2023 at 03:00 PM in Courtroom 4B before Judge Colm F. Connolly. A Bench Trial is set for 5/1/2023 at 08:30 AM in Courtroom 4B before Judge Colm F. Connolly. Signed by Judge Colm F. Connolly on 6/24/2022. (nmf) |
| Jun 21, 2022 | 60 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiff's Identification of Claim Terms for Construction and Proposed Constructions filed by Eagle Pharmaceuticals, Inc..(Joyce, Alexandra) |
| Jun 21, 2022 | 61 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Defendant's Identification of Claim Terms for Construction and Proposed Constructions filed by Celerity Pharmaceuticals, LLC.(Rovner, Philip) |
| Jun 17, 2022 | 59 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiff's Initial Infringement Contentions for Defendant Celerity Pharmaceuticals, LLC filed by Eagle Pharmaceuticals, Inc..(Joyce, Alexandra) |
| Jun 10, 2022 | 58 | Redacted Document (18) Docket Text: REDACTED VERSION of [57] Reply Brief in Support of Motion for Judgment on the Pleadings by Celerity Pharmaceuticals, LLC. (Rovner, Philip) |
| Jun 6, 2022 | 56 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Celerity's Objections and Responses to Plaintiff's First Set of Interrogatories [Confidential - Subject to Protective Order - Counsels' Eyes Only]; and Celerity's Objections and Responses to Plaintiff's First Set of Requests for Production filed by Celerity Pharmaceuticals, LLC.(Rovner, Philip) |
| Jun 3, 2022 | 54 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of 1) Plaintiff's Responses to Defendant's First Set of Request for Production of Documents and (2) Plaintiff's Responses to Defendant's First Set of Interrogatories filed by Eagle Pharmaceuticals, Inc..(Silver, Daniel) |
| Jun 3, 2022 | 55 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Celerity's Initial Non-Infringement Contentions; and Celerity's Initial Invalidity Contentions filed by Celerity Pharmaceuticals, LLC.(Rovner, Philip) |
| May 31, 2022 | 53 | Redacted Document (30) Docket Text: REDACTED VERSION of [48] Answering Brief in Opposition, by Eagle Pharmaceuticals, Inc.. (Joyce, Alexandra) |
| May 26, 2022 | 52 | SO ORDERED (3) Docket Text: SO ORDERED, re [51] Joint STIPULATION TO EXTEND TIME to file Reply Brief in further support of Defendant's Motion for Judgment on the Pleadings to June 7, 2022, filed by Celerity Pharmaceuticals, LLC. Re-Set Briefing Schedule: re [37] MOTION for Judgment on the Pleadings . Reply Brief due 6/7/2022. Signed by Judge Colm F. Connolly on 5/26/2022. (kmd) |
| May 25, 2022 | 50 | SO ORDERED (3) Docket Text: SO ORDERED, re [49] STIPULATION TO EXTEND TIME for Plaintiff's to file a public version of its Answering Brief in Opposition to Celerity's Motion for Judgment on the Pleadings (D.I. 48) to May 31, 2022, filed by Eagle Pharmaceuticals, Inc. Signed by Judge Colm F. Connolly on 5/25/2022. (kmd) |
| May 25, 2022 | 51 | Stipulation to EXTEND Time (3) Docket Text: Joint STIPULATION TO EXTEND TIME to file Reply Brief in further support of Defendant's Motion for Judgment on the Pleadings to June 7, 2022 - filed by Celerity Pharmaceuticals, LLC. (Rovner, Philip) |
| May 24, 2022 | 49 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME for Plaintiff's to file a public version of its Answering Brief in Opposition to Celerity's Motion for Judgment on the Pleadings (D.I. 48) to May 31, 2022 - filed by Eagle Pharmaceuticals, Inc.. (Joyce, Alexandra) |
| May 6, 2022 | 46 | Proposed Order (24) Docket Text: PROPOSED ORDER Scheduling Order by Eagle Pharmaceuticals, Inc.. (Silver, Daniel) |
| May 6, 2022 | 47 | Letter (2) Docket Text: Letter to The Honorable Colm F. Connolly from Daniel M. Silver regarding the Court's Order of April 6, 2022 regarding the case schedule - re [46] Proposed Order. (Silver, Daniel) |
| Apr 26, 2022 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Rebecca Lynne Neubauer for Eagle Pharmaceuticals, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) |
| Apr 26, 2022 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Kamilah Alexander for Eagle Pharmaceuticals, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) |
| Apr 26, 2022 | 45 | Redacted Document (30) Docket Text: REDACTED VERSION of [38] Opening Brief in Support of Motion for Judgment on the Pleadings by Celerity Pharmaceuticals, LLC. (Rovner, Philip) |
| Apr 25, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [43] MOTION for Pro Hac Vice Appearance of Attorney Rebecca Neubauer and Kamilah Alexander filed by Eagle Pharmaceuticals, Inc. Signed by Judge Colm F. Connolly on 4/25/2022. (nmf) |
| Apr 22, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [44] STIPULATION TO EXTEND TIME (1) Plaintiff's deadline to file answering brief in opposition to Motion for Judgment on the Pleadings, and (2) Defendant's deadline to file reply brief in support of Motion for Judgment on the Pleadings to (1) May filed by Eagle Pharmaceuticals, Inc., [37] MOTION for Judgment on the Pleadings filed by Celerity Pharmaceuticals, LLC, Set Briefing Schedule: re [37] MOTION for Judgment on the Pleadings . (Answering Brief due 5/17/2022., Reply Brief due 5/31/2022.) Signed by Judge Colm F. Connolly on 4/22/2022. (nmf) |
| Apr 22, 2022 | 42 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Plaintiff's First Set of Requests for Production to Defendant, and (2) Plaintiff's First Set of Interrogatories to Defendant filed by Eagle Pharmaceuticals, Inc..(Joyce, Alexandra) |
| Apr 22, 2022 | 43 | Motion for Leave to Appear Pro Hac Vice (4) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Rebecca Neubauer and Kamilah Alexander - filed by Eagle Pharmaceuticals, Inc.. (Joyce, Alexandra) |
| Apr 22, 2022 | 44 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME (1) Plaintiff's deadline to file answering brief in opposition to Motion for Judgment on the Pleadings, and (2) Defendant's deadline to file reply brief in support of Motion for Judgment on the Pleadings to (1) May 17, 2022, and (2) May 31, 2022 - filed by Eagle Pharmaceuticals, Inc.. (Joyce, Alexandra) |
| Apr 21, 2022 | 41 | Notice (Other) (2) Docket Text: NOTICE of Withdrawal of Angela C. Whitesell as Counsel by Eagle Pharmaceuticals, Inc. (Whitesell, Angela) |
| Apr 20, 2022 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: D.I. [36] has been replaced to reflect the correct pagination. (kmd) |
| Apr 20, 2022 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Alex M. Grabowski for Eagle Pharmaceuticals, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) |
| Apr 20, 2022 | 39 | Protective Order (30) Docket Text: PROTECTIVE ORDER. Signed by Judge Colm F. Connolly on 4/20/2022. (kmd) |
| Apr 20, 2022 | 40 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Celerity Pharmaceuticals, LLC's First Set of Interrogatories to Eagle Pharmaceuticals, Inc.; and Celerity Pharmaceuticals, LLC's First Set of Requests for Production of Documents to Eagle Pharmaceuticals, Inc. filed by Celerity Pharmaceuticals, LLC.(Rovner, Philip) |
| Apr 19, 2022 | 36 | Proposed Order (30) Docket Text: PROPOSED ORDER Protective Order by Eagle Pharmaceuticals, Inc.. (Joyce, Alexandra) (Main Document 36 replaced on 4/20/2022) (kmd). |
| Apr 19, 2022 | 37 | Main Document (2) Docket Text: MOTION for Judgment on the Pleadings - filed by Celerity Pharmaceuticals, LLC. (Attachments: # (1) Text of Proposed Order)(Rovner, Philip) |
| Apr 19, 2022 | 37 | Text of Proposed Order (1) |
| Apr 18, 2022 | 34 | Redacted Document (9) Docket Text: REDACTED VERSION of [32] Answer to Counterclaim by Eagle Pharmaceuticals, Inc.. (Silver, Daniel) |
| Apr 18, 2022 | 35 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Plaintiff Eagle Pharmaceutical, Inc.'s Initial Disclosures Pursuant to Fed. R. Civ. P. 26(A), and (2) Plaintiff Eagle Pharmaceutical, Inc.'s Initial Disclosures Pursuant to Delaware Default Standard for Discovery filed by Eagle Pharmaceuticals, Inc..(Joyce, Alexandra) |
| Apr 15, 2022 | 33 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Celerity Pharmaceuticals LLC's Disclosures Pursuant to Paragraph 3 of The District of Delaware Default Standard for Discovery; and Celerity Pharmaceuticals LLC's Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1)(A) filed by Celerity Pharmaceuticals, LLC.(Rovner, Philip) |
| Apr 11, 2022 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Kenneth G. Schuler and Marc N. Zubick for Eagle Pharmaceuticals, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) |
| Apr 6, 2022 | 31 | Order (1) Docket Text: ORDER, this case having been recently joined and ready for scheduling pursuant to Fed. R. Civ. P. 16 and as this case is listed as related to earlier filed cases that are currently proceeding on an agreed upon schedule entered by the Court; IT IS ORDERED that, on or before May 6, 2022, counsel for the parties shall confer regarding coordination of the cases and submit a proposed scheduling order to the Court or otherwise advise the Court that a separate scheduling conference is needed. ORDER, Setting Deadlines: ( Notice of Compliance deadline set for 5/6/2022.) Signed by Judge Colm F. Connolly on 4/6/2022. (nmf) |
| Apr 1, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [30] MOTION for Pro Hac Vice Appearance of Attorney Jonathan D.J. Loeb, Ph.D., filed by Celerity Pharmaceuticals, LLC. Ordered by Judge Colm F. Connolly on 4/1/2022. (kmd) |
| Apr 1, 2022 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Jonathan D.J. Loeb for Celerity Pharmaceuticals, LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) |
| Mar 31, 2022 | 30 | Motion for Leave to Appear Pro Hac Vice (3) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Jonathan D.J. Loeb, Ph.D. - filed by Celerity Pharmaceuticals, LLC. (Rovner, Philip) |
| Mar 30, 2022 | 28 | Main Document (41) Docket Text: REDACTED VERSION of [26] Answer to Amended Complaint, Counterclaim by Celerity Pharmaceuticals, LLC. (Attachments: # (1) Exhibit 1-7)(Rovner, Philip) |
| Mar 30, 2022 | 28 | Exhibit 1-7 (18) |
| Mar 30, 2022 | 29 | SO ORDERED (3) Docket Text: SO ORDERED, re [27] STIPULATION TO EXTEND TIME to file a public version of its Answer to First Amended Complaint and Counterclaims to April 1, 2022, filed by Celerity Pharmaceuticals, LLC. Signed by Judge Colm F. Connolly on 3/30/2022. (kmd) |
| Mar 29, 2022 | 27 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME to file a public version of its Answer to First Amended Complaint and Counterclaims to April 1, 2022 - filed by Celerity Pharmaceuticals, LLC. (Rovner, Philip) |
| Mar 18, 2022 | 25 | Main Document (20) Docket Text: REDACTED VERSION of [19] Amended Complaint by Eagle Pharmaceuticals, Inc.. (Attachments: # (1) Exhibits A-Q)(Joyce, Alexandra) |
| Mar 18, 2022 | 25 | Exhibits A-Q (330) |
| Mar 18, 2022 | 25 | Amended Complaint* (1) |
| Mar 17, 2022 | 24 | SO ORDERED (3) Docket Text: SO ORDERED, re [23] STIPULATION TO EXTEND TIME for Plaintiff to file a public version of the First Amended Complaint (D.I. 19) pursuant to section G of the Administrative Procedures Governing Filing and Service by Electronic Means to March 18, 2022, filed by Eagle Pharmaceuticals, Inc. Signed by Judge Colm F. Connolly on 3/17/2022. (kmd) |
| Mar 15, 2022 | 23 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME for Plaintiff to file a public version of the First Amended Complaint (D.I. 19) pursuant to section G of the Administrative Procedures Governing Filing and Service by Electronic Means to March 18, 2022 - filed by Eagle Pharmaceuticals, Inc.. (Joyce, Alexandra) |
| Mar 14, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [22] STIPULATION TO EXTEND TIME for Defendant to answer, move or otherwise respond to Plaintiff's First Amended Complaint to March 22, 2022, filed by Celerity Pharmaceuticals, LLC. Reset Answer Deadlines: Celerity Pharmaceuticals, LLC answer due 3/22/2022. Ordered by Judge Colm F. Connolly on 3/14/2022. (kmd) |
| Mar 11, 2022 | 22 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME for Defendant to answer, move or otherwise respond to Plaintiff's First Amended Complaint to March 22, 2022 - filed by Celerity Pharmaceuticals, LLC. (Rovner, Philip) |
| Mar 10, 2022 | 21 | SO ORDERED (3) Docket Text: SO ORDERED, re [20] STIPULATION TO EXTEND TIME for Plaintiff to file a public version of the First Amended Complaint (D.I. 19) pursuant to section G of the Administrative Procedures Governing Filing and Service by Electronic Means to March 15, 2022, filed by Celerity Pharmaceuticals, LLC. Signed by Judge Colm F. Connolly on 3/10/2022. (kmd) (Main Document 21 replaced on 3/10/2022) (kmd). |
| Mar 8, 2022 | 20 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME for Plaintiff to file a public version of the First Amended Complaint (D.I. 19) pursuant to section G of the Administrative Procedures Governing Filing and Service by Electronic Means to March 15, 2022 - filed by Celerity Pharmaceuticals, LLC. (Rovner, Philip) |
| Mar 2, 2022 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorneys Robert D. Rhoad, Amanda K. Antons, Judah Bellin for Celerity Pharmaceuticals, LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (twk) |
| Feb 17, 2022 | 18 | SO ORDERED (3) Docket Text: SO ORDERED, re [16] STIPULATION TO EXTEND TIME (1) to file Answering Brief in opposition to the Motion to Dismiss, or (2) Amend the Complaint to (1) March 16, 2022, and (2) March 1, 2022, filed by Eagle Pharmaceuticals, Inc. Re-Set Briefing Schedule: re [9] MOTION to Dismiss for Failure to State a Claim. Answering Brief due 3/1/2022. Signed by Judge Colm F. Connolly on 2/17/2022. (kmd) |
| Feb 16, 2022 | 16 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME (1) to file Answering Brief in opposition to the Motion to Dismiss, or (2) Amend the Complaint to (1) March 16, 2022, and (2) March 1, 2022 - filed by Eagle Pharmaceuticals, Inc.. (Silver, Daniel) |
| Feb 16, 2022 | 17 | Notice of Appearance (2) Docket Text: NOTICE of Appearance by Angela Whitesell on behalf of Eagle Pharmaceuticals, Inc. (Whitesell, Angela) |
| Feb 10, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [15] MOTION for Pro Hac Vice Appearance of Attorney Martin J. Black, Robert D. Rhoad, Judah Bellin and Amanda K. Antons, filed by Celerity Pharmaceuticals, LLC. Ordered by Judge Colm F. Connolly on 2/10/2022. (kmd) |
| Feb 10, 2022 | 15 | Motion for Leave to Appear Pro Hac Vice (7) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Martin J. Black, Robert D. Rhoad, Judah Bellin and Amanda K. Antons - filed by Celerity Pharmaceuticals, LLC. (Rovner, Philip) |
| Feb 9, 2022 | 13 | Redacted Document (30) Docket Text: REDACTED VERSION of [10] Opening Brief in Support of Motion to Dismiss for Failure to State a Claim by Celerity Pharmaceuticals, LLC. (Rovner, Philip) |
| Feb 9, 2022 | 14 | Main Document (2) Docket Text: REDACTED VERSION of [11] Declaration of Amanda K. Antons by Celerity Pharmaceuticals, LLC. (Attachments: # (1) Exhibit A-D)(Rovner, Philip) |
| Feb 9, 2022 | 14 | Exhibit A-D (99) |
| Feb 2, 2022 | 9 | Main Document (2) Docket Text: MOTION to Dismiss for Failure to State a Claim - filed by Celerity Pharmaceuticals, LLC. (Attachments: # (1) Text of Proposed Order)(Rovner, Philip) |
| Feb 2, 2022 | 9 | Text of Proposed Order (1) |
| Feb 2, 2022 | 12 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Celerity Pharmaceutical Holdings, LLC for Celerity Pharmaceuticals, LLC filed by Celerity Pharmaceuticals, LLC. (Rovner, Philip) |
| Jan 28, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [8] MOTION for Pro Hac Vice Appearance of Attorney Kenneth G. Schulr, Marc N. Zubick, Alex Grabowski, Daniel G. Brown, and Jennifer Koh, filed by Eagle Pharmaceuticals, Inc. Ordered by Judge Colm F. Connolly on 1/28/2022. (kmd) |
| Jan 28, 2022 | 8 | Motion for Leave to Appear Pro Hac Vice (7) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Kenneth G. Schuler, Marc N. Zubick, Alex Grabowski, Daniel G. Brown, and Jennifer Koh - filed by Eagle Pharmaceuticals, Inc.. (Joyce, Alexandra) Modified on 1/28/2022 (kmd). |
| Jan 19, 2022 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (rjb) |
| Jan 12, 2022 | 7 | Return of Service Executed (2) Docket Text: Return of Service Executed by Eagle Pharmaceuticals, Inc.. Celerity Pharmaceuticals, LLC served on 1/12/2022, answer due 2/2/2022. (Silver, Daniel) |
| Jan 11, 2022 | 1 | Main Document (8) Docket Text: COMPLAINT filed against Celerity Pharmaceuticals, LLC - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3779374.) - filed by Eagle Pharmaceuticals, Inc.. (Attachments: # (1) Exhibit A, # (2) Civil Cover Sheet)(srs) |
| Jan 11, 2022 | 1 | Exhibit A (13) |
| Jan 11, 2022 | 1 | Civil Cover Sheet (3) |
| Jan 11, 2022 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (srs) |
| Jan 11, 2022 | 3 | ANDA Form (2) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: December 3, 2021. Date of Expiration of Patent: January 28, 2031.Thirty Month Stay Deadline: 6/3/2024. (srs) |
| Jan 11, 2022 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 11,103,483. (srs) |
| Jan 11, 2022 | 5 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate Janus Henderson Group PLC and Other Affiliate BlackRock Instructional Trust Company, N.A. for Eagle Pharmaceuticals, Inc. filed by Eagle Pharmaceuticals, Inc. (srs) |
| Jan 11, 2022 | 6 | Summons Issued (2) Docket Text: Summons Issued with Magistrate Consent Notice attached as to Celerity Pharmaceuticals, LLC on 1/11/2022. (srs) |
| Jan 11, 2022 | 1 | Complaint* (1) |
